The ROE as of September 2024 (TTM) for Castle Biosciences, Inc. (CSTL) is -0.77%

According to Castle Biosciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -0.77%. This represents a change of 217.31% compared to the average of -0.24% of the last 4 quarters.

Castle Biosciences, Inc. (CSTL) Historical ROE (quarterly & annually)

How has CSTL ROE performed in the past?

The mean historical ROE of Castle Biosciences, Inc. over the last ten years is 16.36%. The current -0.77% ROE has changed -104.73% with respect to the historical average. Over the past ten years (40 quarters), CSTL's ROE was at its highest in in the June 2019 quarter at 35.31%. The ROE was at its lowest in in the March 2019 quarter at -67.86%.

Castle Biosciences, Inc. (CSTL) ROE by Quarter and Year

Discovering the peaks and valleys of Castle Biosciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Castle Biosciences, Inc. (CSTL) Average ROE

How has CSTL ROE performed in the past?

The current ROE of Castle Biosciences, Inc. (CSTL) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Castle Biosciences, Inc. (CSTL) ROE vs. Peers

How is CSTL’s ROE compared to its peers?

Castle Biosciences, Inc.’s ROE is greater than CareDx, Inc (-54.28%), greater than Twist Bioscience Corporation (-38.91%), greater than Biodesix, Inc. (-525.32%), greater than Natera, Inc. (-36.74%), greater than Genetron Holdings Limited (-36.51%), greater than Olink Holding AB (publ) (-7.07%), less than FONAR Corporation (9.60%), greater than Exagen Inc. (-78.90%), greater than Personalis, Inc. (-63.43%), greater than Guardant Health, Inc. (-432.71%), greater than Burning Rock Biotech Limited (-74.92%), greater than Sera Prognostics, Inc. (-46.71%), less than LumiraDx Limited (122.57%), greater than Neuronetics, Inc. (-109.00%), less than Enzo Biochem, Inc. (61.16%),

Build a custom stock screener for Castle Biosciences, Inc. (CSTL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Castle Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Castle Biosciences, Inc. (CSTL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Castle Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.